Physician

Mansoor Javeed, M.D.

According to 2025 Medicare claims, Mansoor Javeed, M.D. (NPI: 1205802907) practices hematology/oncology in the Sacramento-Roseville-Folsom, CA market, with the plurality of this provider's patient population coming from Sacramento, CA. This provider's primary affiliated billing organization is HEMATOLOGY AND ONCOLOGY ASSOCIATES OF NORTHERN CALIFORNIA (NPI: 1346757135; TIN: 823144766) and primary practice location at 95630-3820.

Javeed's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 408 traditional Medicare patients, billed 203,872 HCPCS/CPT codes, and received $2,790,732 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 714 prescription claims across 121 beneficiaries totaling $4,118,988 in drug costs, led by Brukinsa (Zanubrutinib). 2022 DME data shows 14 claims. Open Payments data shows 91 records totaling $2,598. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $1,320,941 to $2,790,732. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $1,433,486 to $4,118,988. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	369	177,965	$1,320,941
2016	326	126,033	$1,386,983
2017	293	142,381	$1,620,142
2018	303	144,193	$1,593,790
2019	319	257,567	$1,907,303
2020	358	273,062	$2,699,095
2021	347	223,115	$2,805,398
2022	326	162,881	$1,845,138
2023	346	180,801	$1,939,962
2024	408	203,872	$2,790,732

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	141	1,004	$1,433,486
2016	139	856	$1,291,942
2017	153	998	$1,526,547
2018	148	828	$1,223,438
2019	154	861	$1,608,614
2020	153	876	$2,599,530
2021	141	878	$3,103,029
2022	131	829	$2,657,012
2023	120	736	$3,460,847
2024	121	714	$4,118,988

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	34	175	$29,168
2016	N/R	124	$31,964
2017	N/R	36	$9,814
2018	N/R	38	$2,995
2019	N/R	N/R	N/R
2020	N/R	57	$3,938
2021	N/R	106	$6,065
2022	N/R	14	$613
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	49	49	$197
96413	Administration of chemotherapy into vein, 1 hour or less	41	394	$122
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	176	666	$98
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	335	842	$66
96372	Injection of drug or substance under skin or into muscle	33	309	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Brukinsa	Zanubrutinib	36	1,065	$509,963
Calquence	Acalabrutinib Maleate	35	1,050	$507,706
Imbruvica	Ibrutinib	26	734	$405,845
Xtandi	Enzalutamide	27	810	$380,387
Jaypirca	Pirtobrutinib	16	480	$359,853

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	91	$2,598	PFIZER INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Mansoor Javeed, M.D.?

Tedicare shows public-source Medicare data for Mansoor Javeed, M.D. (NPI 1205802907), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mansoor Javeed, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Mansoor Javeed, M.D.?

Mansoor Javeed, M.D. is linked to HEMATOLOGY AND ONCOLOGY ASSOCIATES OF NORTHERN CALIFORNIA (billing NPI 1346757135) in the available physician profile data.

Does Mansoor Javeed, M.D. have Open Payments data?

Mansoor Javeed, M.D. has 91 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.